Beijing Airdoc Technology Co., Ltd. (AIRDOC-B) aksje

Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. It offers AI-FUNDUSCAMERA-P, a portable, automated, and self-service fundus camera that enables retinal image acquisition; AI-FUNDUSCAMERA-U, a portable fundus camera for the popularization of eye health services; and AI-FUNDUSCAMERA-H, a multimodal health scanner integrating biosensors. The company also provides AI-FUNDUSCAMERA-M, a portable intelligent image capture terminal; Airdoc-AIFUNDUS products for auxiliary diagnostic services to tertiary hospitals, primary healthcare institutions, and health checkup centers; and Airdoc vision rehabilitation instrument, a medical device to prevent axial myopia and aids in the auxiliary treatment of myopia. In addition, it offers Airdoc Neuro-AI, a non-contact measurement product for stress resilience, and physiological and psychological stress; risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease, and anemia. The company was formerly known as Beijing Tulip Partner Technology Co., Ltd. and changed its name to Beijing Airdoc Technology Co., Ltd. in December 2020. Beijing Airdoc Technology Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, the People's Republic of China.